Innate-like and conventional T cell populations from hemodialyzed and kidney transplanted patients are equally compromised

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Baron, Marine ^a   Belo, Renata ^a   Cathelin, Dominique ^b,c   Moreira Teixeira, Lucia ^a   Cartery, Claire ^d   Rondeau, Eric ^b,c   Mesnard, Laurent ^b,c   Leite de Moraes, Maria ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD161 ANTIGEN; CD3 ANTIGEN; CD45RA ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; CYTOKINE;

ADULT; ARTICLE; BLOOD SAMPLING; CD4 CD8 RATIO; CD4+ T LYMPHOCYTE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; IMMUNE DYSREGULATION; IMMUNOCOMPROMISED PATIENT; INFECTION RISK; INNATE LIKE T LYMPHOCYTE; INVARIANT NATURAL KILLER T CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MAJOR CLINICAL STUDY; MALE; MUCOSA ASSOCIATED INVARIANT T LYMPHOCYTE; NATURAL KILLER T CELL; PATIENT HISTORY OF KIDNEY TRANSPLANTATION; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; IMMUNOCOMPROMIZED PATIENT; IMMUNOLOGY; IMMUNOPHENOTYPING; INNATE IMMUNITY; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; METABOLISM; MIDDLE AGED; PHENOTYPE; RENAL REPLACEMENT THERAPY; YOUNG ADULT;

ADULT; CYTOKINES; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOCOMPROMISED HOST; IMMUNOPHENOTYPING; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; PHENOTYPE; RENAL DIALYSIS; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 84940279487     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105422     Document Type: Article

References (25)

1. Sarnak MJ, Jaber BL (2000) Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 58: 1758-1764.
2. Jaber BL (2005) Bacterial infections in hemodialysis patients: pathogenesis and prevention. Kidney Int 67: 2508-2519.
3. Lewis SL, Van Epps DE (1987) Neutrophil and monocyte alterations in chronic dialysis patients. Am J Kidney Dis 9: 381-395. (Pubitemid 17090636)
4. Jaber BL, Cendoroglo M, Balakrishnan VS, Perianayagam MC, King AJ, et al. (2001) Apoptosis of leukocytes: basic concepts and implications in uremia. Kidney Int Suppl 78: S197-205. (Pubitemid 32144098)
5. Vanholder R, Ringoir S (1993) Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review. J Am Soc Nephrol 3: 1541-1554.
6. Verkade MA, van Druningen CJ, Vaessen LM, Hesselink DA, Weimar W, et al. (2007) Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. Nephrol Dial Transplant 22: 128-138. (Pubitemid 46050337)
7. Raska K Jr, Raskova J, Shea SM, Frankel RM, Wood RH, et al. (1983) T cell subsets and cellular immunity in end-stage renal disease. Am J Med 75: 734-740. (Pubitemid 13023279)
8. Peraldi MN, Berrou J, Metivier F, Toubert A (2013) Natural killer cell dysfunction in uremia: the role of oxidative stress and the effects of dialysis. Blood Purif, 35 Suppl 2:14-19.
9. Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336. (Pubitemid 46697911)
10. Kronenberg M (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23: 877-900.
11. Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, et al. (2011) Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 32: 212-218.
12. Moreira-Teixeira L, Resende M, Coffre M, Devergne O, Herbeuval JP, et al. (2011) Proinflammatory environment dictates the IL-17-producing capacity of human invariant NKT cells. J Immunol 186: 5758-5765.
13. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, et al. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 278: 1626-1629. (Pubitemid 27516282)
14. Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, et al. (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491: 717-723.
15. Berzins SP, Smyth MJ, Baxter AG (2011) Presumed guilty: natural killer T cell defects and human disease. Nat Rev Immunol 11: 131-142.
16. Paget C, Trottein F (2013) Role of type 1 natural killer T cells in pulmonary immunity. Mucosal Immunol 6: 1054-1067.
17. Le Bourhis L, Guerri L, Dusseaux M, Martin E, Soudais C, et al. (2011) Mucosal-associated invariant T cells: unconventional development and function. Trends Immunol 32: 212-218.
18. Mesnard L, Keller AC, Michel ML, Vandermeersch S, Rafat C, et al. (2009) Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis. J Am Soc Nephrol 20: 1282-1292.
19. Moreira-Teixeira L, Resende M, Devergne O, Herbeuval JP, Hermine O, et al. (2012) Rapamycin combined with TGF-beta converts human invariant NKT cells into suppressive Foxp3+ regulatory cells. J Immunol 188: 624-631.
20. Deenitchina SS, Ando T, Okuda S, Kinukawa N, Hirakata H, et al. (1995) Cellular immunity in hemodialysis patients: a quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol 15: 57-65. (Pubitemid 24373044)
21. Cypowyj S, Picard C, Marodi L, Casanova JL, Puel A (2012) Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol 42: 2246-2254.
22. Kim YG, Kim EY, Ihm CG, Lee TW, Lee SH, et al. (2012) Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease. Am J Nephrol 36: 472-477.
23. Ziegler SF (2006) FOXP3: of mice and men. Annu Rev Immunol 24: 209-226.
24. Gavin MA, Rasmussen JP, Fontenot JD, Vasta V, Manganiello VC, et al. (2007) Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445: 771-775. (Pubitemid 46279714)
25. Miyara M, Yoshioka Y, Kitoh A, Shima T, Wing K, et al. (2009) Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity 30: 899-911.